Cure My Disease

Don't miss your cure!

 Log in / Sign up

Airport Workers' lungs under the microscope: 5-Year study on jet nanoparticles

NCT ID NCT02872727

Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 216 Air France employees working at Paris and Marseille airports to see if tiny particles from aircraft engines affect their breathing over 5 years. Researchers measured lung function and exposure to nanoparticles. The goal was to understand any link between these particles and changes in respiratory health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

216 people

The number who actually took part.

Started

Dec 2017

Finished

Jun 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All subjects previously included in our previous study (RBC No: 2011-A00646-35; NCT03098784).

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject must be given free and informed consent and signed the consent * Subject must be affiliated or beneficiary in a health insurance plan * Subject included in our previous study (RBC No: 2011-A00646-35; NCT03098784) Exclusion Criteria: \- Subject has a cons-indication (or an incompatible combination therapy) for the realization of the EFR.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Air france company's employees working in the marseilles and paris airports (flightline and administrative employees) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Air france company's employees working in the marseilles and paris airports (flightline and administrative employees)

Contacts and locations

Locations

  • Uhmontpellier

    Montpellier, Montpellier, 34295, France